Real-world studies no substitute for RCTs in establishing efficacy

Affiliations

¹ Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON L8S4K1, Canada. Electronic address: gerstein@mcmaster.ca.
² University of Glasgow, BHF Cardiovascular Research Centre, Glasgow, UK.
³ Diabetes Trials Unit, University of Oxford, Oxford, UK.

Hertzel C Gerstein et al. Lancet. 2019.

. 2019 Jan 19;393(10168):210-211.

doi: 10.1016/S0140-6736(18)32840-X.

¹ Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON L8S4K1, Canada. Electronic address: gerstein@mcmaster.ca.
² University of Glasgow, BHF Cardiovascular Research Centre, Glasgow, UK.
³ Diabetes Trials Unit, University of Oxford, Oxford, UK.

No abstract available

Comment in

The importance of randomised vs non-randomised trials.
Djulbegovic B, Glasziou P, Chalmers I. Djulbegovic B, et al. Lancet. 2019 Aug 24;394(10199):634-635. doi: 10.1016/S0140-6736(19)31128-6. Lancet. 2019. PMID: 31448731 No abstract available.
The importance of randomised vs non-randomised trials.
Rieckmann A, Benn CS. Rieckmann A, et al. Lancet. 2019 Aug 24;394(10199):634. doi: 10.1016/S0140-6736(19)31129-8. Lancet. 2019. PMID: 31448732 No abstract available.